Get started
Work

Inhibiting RIPK1 Kinase Activity Is Protective in Experimental Models of COPD

Year: 2022
Type: conference-abstract
DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2407
Authors: H.P. Van Eeckhoutte, C. Donovan, R. Kim, H. Khan, R. Jayaraman, Y. Dondelinger, T. Delanghe, A. Beal, B. Geddes, J. Bertin, T. Vanden Berghe, P. Vandenabeele, B. Vanaudenaerde, D. Deforce, S. Skevin, F. Van Nieuwerburgh, F. Verhamme, G. Joos, G.G. Brusselle, M. Bertrand, P. Hansbro, K. Bracke
Institutions: Ghent University Hospital, University of Technology Sydney, Centenary Institute, Ghent University, VIB-UGent Center for Inflammation Research, GlaxoSmithKline (United States), Sanofi (United States), University of Antwerp, KU Leuven
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W4225319199
Cites:
Cited by: 2
Related to: 10